ocrelizumab-ocsq 40 MG/ML
RxNorm concept 2693450, clinical drug component (scdc).
- RxCUI
- 2693450
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection (SCD, constitutes)
- 23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo] (SBD, constitutes)
- ocrelizumab (IN, has ingredient)
- ocrelizumab-ocsq (PIN, has precise ingredient)
- hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML [Ocrevus Zunovo] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2693450 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2693450. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.